These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24387824)

  • 1. Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma.
    Bonekamp D; Bonekamp S; Halappa VG; Geschwind JF; Eng J; Corona-Villalobos CP; Pawlik TM; Kamel IR
    Eur J Radiol; 2014 Mar; 83(3):487-96. PubMed ID: 24387824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiologic-pathologic analysis of contrast-enhanced and diffusion-weighted MR imaging in patients with HCC after TACE: diagnostic accuracy of 3D quantitative image analysis.
    Chapiro J; Wood LD; Lin M; Duran R; Cornish T; Lesage D; Charu V; Schernthaner R; Wang Z; Tacher V; Savic LJ; Kamel IR; Geschwind JF
    Radiology; 2014 Dec; 273(3):746-58. PubMed ID: 25028783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response Evaluation of Malignant Liver Lesions After TACE/SIRT: Comparison of Manual and Semi-Automatic Measurement of Different Response Criteria in Multislice CT.
    Höink AJ; Schülke C; Koch R; Löhnert A; Kammerer S; Fortkamp R; Heindel W; Buerke B
    Rofo; 2017 Nov; 189(11):1067-1075. PubMed ID: 28834965
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of HCC response to locoregional therapy: Validation of MRI-based response criteria versus explant pathology.
    Gordic S; Corcuera-Solano I; Stueck A; Besa C; Argiriadi P; Guniganti P; King M; Kihira S; Babb J; Thung S; Taouli B
    J Hepatol; 2017 Dec; 67(6):1213-1221. PubMed ID: 28823713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional magnetic resonance imaging response of targeted tumor burden and its impact on survival in patients with hepatocellular carcinoma.
    Corona-Villalobos CP; Halappa VG; Bonekamp S; Eng J; Reyes D; Cosgrove D; Rastegar N; Pan L; Pawlik TM; Kamel IR
    Invest Radiol; 2015 Apr; 50(4):283-9. PubMed ID: 25396692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative and volumetric European Association for the Study of the Liver and Response Evaluation Criteria in Solid Tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization.
    Lin M; Pellerin O; Bhagat N; Rao PP; Loffroy R; Ardon R; Mory B; Reyes DK; Geschwind JF
    J Vasc Interv Radiol; 2012 Dec; 23(12):1629-37. PubMed ID: 23177109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy.
    Bonekamp S; Halappa VG; Geschwind JF; Li Z; Corona-Villalobos CP; Reyes D; Bhagat N; Cosgrove DP; Pawlik TM; Mezey E; Eng J; Kamel IR
    Radiology; 2013 Aug; 268(2):431-9. PubMed ID: 23616632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data.
    Bonekamp S; Jolepalem P; Lazo M; Gulsun MA; Kiraly AP; Kamel IR
    Radiology; 2011 Sep; 260(3):752-61. PubMed ID: 21771960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome.
    Vandecaveye V; Michielsen K; De Keyzer F; Laleman W; Komuta M; Op de beeck K; Roskams T; Nevens F; Verslype C; Maleux G
    Radiology; 2014 Mar; 270(3):747-57. PubMed ID: 24475816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Staging Markers for Hepatocellular Carcinoma before Transarterial Chemoembolization: Comparison of Three-dimensional Quantitative versus Non-three-dimensional Imaging Markers.
    Chapiro J; Duran R; Lin M; Schernthaner RE; Wang Z; Gorodetski B; Geschwind JF
    Radiology; 2015 May; 275(2):438-47. PubMed ID: 25531387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline and Early MR Apparent Diffusion Coefficient Quantification as a Predictor of Response of Unresectable Hepatocellular Carcinoma to Doxorubicin Drug-Eluting Bead Chemoembolization.
    Kokabi N; Ludwig JM; Camacho JC; Xing M; Mittal PK; Kim HS
    J Vasc Interv Radiol; 2015 Dec; 26(12):1777-86. PubMed ID: 26603497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part I. Identification and validation of volumetric functional response criteria.
    Bonekamp S; Li Z; Geschwind JF; Halappa VG; Corona-Villalobos CP; Reyes D; Pawlik TM; Bonekamp D; Eng J; Kamel IR
    Radiology; 2013 Aug; 268(2):420-30. PubMed ID: 23616631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response Evaluation Criteria in Solid Tumors (RECIST) criteria are superior to European Association for Study of the Liver (EASL) criteria at 1 month follow-up for predicting long-term survival in patients treated with transarterial chemoembolization before liver transplantation for hepatocellular cancer.
    Shuster A; Huynh TJ; Rajan DK; Marquez MA; Grant DR; Huynh DC; Jaskolka JD
    J Vasc Interv Radiol; 2013 Jun; 24(6):805-12. PubMed ID: 23562641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interreader and inter-test agreement in assessing treatment response following transarterial embolization for hepatocellular carcinoma.
    Donati OF; Do RK; Hötker AM; Katz SS; Zheng J; Moskowitz CS; Beattie C; Brown KT
    Eur Radiol; 2015 Sep; 25(9):2779-88. PubMed ID: 25850892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization.
    Li Z; Bonekamp S; Halappa VG; Corona-Villalobos CP; Pawlik T; Bhagat N; Reyes D; Lai H; Geschwind JF; Kamel IR
    Radiology; 2012 Jul; 264(1):97-109. PubMed ID: 22627602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are pancreatic IPMN volumes measured on MRI images more reproducible than diameters? An assessment in a large single-institution cohort.
    Pandey P; Pandey A; Varzaneh FN; Ghasabeh MA; Fouladi D; Khoshpouri P; Shao N; Zarghampour M; Hruban RH; Canto M; O'Broin-Lennon AM; Kamel IR
    Eur Radiol; 2018 Jul; 28(7):2790-2800. PubMed ID: 29404774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M; Radler E; Ingrisch M; Staehler M; Schmid-Tannwald C; Rist C; Nikolaou K; Reiser MF; Notohamiprodjo M
    Invest Radiol; 2015 Jan; 50(1):57-66. PubMed ID: 25260094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.
    Tacher V; Lin M; Duran R; Yarmohammadi H; Lee H; Chapiro J; Chao M; Wang Z; Frangakis C; Sohn JH; Maltenfort MG; Pawlik T; Geschwind JF
    Radiology; 2016 Jan; 278(1):275-84. PubMed ID: 26131913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-Weighted MRI in Patients with Testicular Tumors-Intra- and Interobserver Variability.
    Pedersen MRV; Loft MK; Dam C; Rasmussen LÆL; Timm S
    Curr Oncol; 2022 Feb; 29(2):837-847. PubMed ID: 35200570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric response classification in metastatic solid tumors on MSCT: initial results in a whole-body setting.
    Wulff AM; Fabel M; Freitag-Wolf S; Tepper M; Knabe HM; Schäfer JP; Jansen O; Bolte H
    Eur J Radiol; 2013 Oct; 82(10):e567-73. PubMed ID: 23827800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.